Mevalonic acid

Mevalonic acid is a lipid of Fatty Acyls (FA) class.

Cross Reference

There are no associated biomedical information in the current reference collection.

Current reference collection contains 10134 references associated with Mevalonic acid in LipidPedia. Due to lack of full text of references or no associated biomedical terms are recognized in our current text-mining method, we cannot extract any biomedical terms related to diseases, pathways, locations, functions, genes, lipids, and animal models from the associated reference collection.

Users can download the reference list at the bottom of this page and read the reference manually to find out biomedical information.


Here are additional resources we collected from PubChem and MeSH for Mevalonic acid

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with Mevalonic acid

MeSH term MeSH ID Detail
Celiac Disease D002446 16 associated lipids
Biliary Fistula D001658 13 associated lipids
Xanthomatosis D014973 17 associated lipids
Smith-Lemli-Opitz Syndrome D019082 7 associated lipids
Peutz-Jeghers Syndrome D010580 2 associated lipids
Per page 10 20 50 | Total 25

PubChem Biomolecular Interactions and Pathways

NCBI Entrez Crosslinks

All references with Mevalonic acid

Download all related citations
Per page 10 20 50 100 | Total 2899
Authors Title Published Journal PubMed Link
Kuroda M et al. Sesquiterpene farnesol inhibits recycling of the C55 lipid carrier of the murein monomer precursor contributing to increased susceptibility to beta-lactams in methicillin-resistant Staphylococcus aureus. 2007 J. Antimicrob. Chemother. pmid:17242033
Hao M et al. Direct effect of cholesterol on insulin secretion: a novel mechanism for pancreatic beta-cell dysfunction. 2007 Diabetes pmid:17575085
Parsons RB et al. A specific inhibitor of cholesterol biosynthesis, BM15.766, reduces the expression of beta-secretase and the production of amyloid-beta in vitro. 2007 J. Neurochem. pmid:17472704
Araki S et al. Simvastatin enhances induction of inducible nitric oxide synthase in 3T3-L1 adipocytes. 2007 Free Radic. Res. pmid:17729120
Maurer-Stroh S et al. Towards complete sets of farnesylated and geranylgeranylated proteins. 2007 PLoS Comput. Biol. pmid:17411337
Llorente A et al. Cholesterol regulates prostasome release from secretory lysosomes in PC-3 human prostate cancer cells. 2007 Eur. J. Cell Biol. pmid:17601634
Jahangir T and Sultana S Perillyl Alcohol Protects Against Fe-NTA-Induced Nephrotoxicity and Early Tumor Promotional Events in Rat Experimental Model. 2007 Evid Based Complement Alternat Med pmid:18227911
Li M et al. Inhibition of serotonin-induced mitogenesis, migration, and ERK MAPK nuclear translocation in vascular smooth muscle cells by atorvastatin. 2007 Am. J. Physiol. Lung Cell Mol. Physiol. pmid:17545489
Merrell MA et al. Inhibition of the mevalonate pathway and activation of p38 MAP kinase are independently regulated by nitrogen-containing bisphosphonates in breast cancer cells. 2007 Eur. J. Pharmacol. pmid:17640631
Wong WW et al. Determinants of sensitivity to lovastatin-induced apoptosis in multiple myeloma. 2007 Mol. Cancer Ther. pmid:17575117
Kutrzeba L et al. Biosynthesis of salvinorin A proceeds via the deoxyxylulose phosphate pathway. 2007 Phytochemistry pmid:17574635
Hunter WN The non-mevalonate pathway of isoprenoid precursor biosynthesis. 2007 J. Biol. Chem. pmid:17442674
Takeda I et al. Simvastatin inactivates beta1-integrin and extracellular signal-related kinase signaling and inhibits cell proliferation in head and neck squamous cell carcinoma cells. 2007 Cancer Sci. pmid:17428261
Roelofs AJ et al. Apomine enhances the antitumor effects of lovastatin on myeloma cells by down-regulating 3-hydroxy-3-methylglutaryl-coenzyme A reductase. 2007 J. Pharmacol. Exp. Ther. pmid:17412884
Henriksson LM et al. Structures of Mycobacterium tuberculosis 1-deoxy-D-xylulose-5-phosphate reductoisomerase provide new insights into catalysis. 2007 J. Biol. Chem. pmid:17491006
Mönkkönen H et al. Zoledronic acid-induced IPP/ApppI production in vivo. 2007 Life Sci. pmid:17850825
Towler MJ and Weathers PJ Evidence of artemisinin production from IPP stemming from both the mevalonate and the nonmevalonate pathways. 2007 Plant Cell Rep. pmid:17710406
Riganti C et al. Asbestos induces nitric oxide synthesis in mesothelioma cells via Rho signaling inhibition. 2007 Am. J. Respir. Cell Mol. Biol. pmid:17322126
Habib A et al. Modulation of COX-2 expression by statins in human monocytic cells. 2007 FASEB J. pmid:17317725
Lee MH et al. Simvastatin suppresses self-renewal of mouse embryonic stem cells by inhibiting RhoA geranylgeranylation. 2007 Stem Cells pmid:17464088
Nakajima H et al. Induction of mitochondria-dependent apoptosis through the inhibition of mevalonate pathway in human breast cancer cells by YM529, a new third generation bisphosphonate. 2007 Cancer Lett. pmid:17316980
Kinjoh T et al. Control of juvenile hormone biosynthesis in Bombyx mori: cloning of the enzymes in the mevalonate pathway and assessment of their developmental expression in the corpora allata. 2007 Insect Biochem. Mol. Biol. pmid:17628279
Saha RN and Pahan K Regulation of inducible nitric oxide synthase gene in glial cells. 2006 May-Jun Antioxid. Redox Signal. pmid:16771683
Seong K et al. Cryptic promoter activity in the coding region of the HMG-CoA reductase gene in Fusarium graminearum. 2006 Fungal Genet. Biol. pmid:16377218
Haratake A et al. Acceleration of de novo cholesterol synthesis in the epidermis influences desquamation of the stratum corneum in aged mice. 2006 Skin Pharmacol Physiol pmid:16778459
Dincer M et al. Statins may decrease skeletal-related events in breast cancer patients with bone metastases. 2006 Med. Hypotheses pmid:16844315
Kwintkiewicz J et al. Mevastatin inhibits proliferation of rat ovarian theca-interstitial cells by blocking the mitogen-activated protein kinase pathway. 2006 Fertil. Steril. pmid:16963032
Pozo M et al. Simvastatin inhibits the migration and adhesion of monocytic cells and disorganizes the cytoskeleton of activated endothelial cells. 2006 Eur. J. Pharmacol. pmid:16973154
Piotrowski PC et al. Statins inhibit growth of human endometrial stromal cells independently of cholesterol availability. 2006 Biol. Reprod. pmid:16571871
Sakoda K et al. Simvastatin decreases IL-6 and IL-8 production in epithelial cells. 2006 J. Dent. Res. pmid:16723648
Kanellis J et al. Activators of the energy sensing kinase AMPK inhibit random cell movement and chemotaxis in U937 cells. 2006 Immunol. Cell Biol. pmid:16405649
Polo MP and de Bravo MG Effect of geraniol on fatty-acid and mevalonate metabolism in the human hepatoma cell line Hep G2. 2006 Biochem. Cell Biol. pmid:16462894
Hampel D et al. Biosynthesis of mono- and sesquiterpenes in strawberry fruits and foliage: 2H labeling studies. 2006 J. Agric. Food Chem. pmid:16478276
Ro DK et al. Production of the antimalarial drug precursor artemisinic acid in engineered yeast. 2006 Nature pmid:16612385
Sjögren B et al. Cholesterol depletion reduces serotonin binding and signaling via human 5-HT(7(a)) receptors. 2006 Eur. J. Pharmacol. pmid:17064686
Ohm TG and Meske V Cholesterol, statins and tau. 2006 Acta Neurol. Scand., Suppl.c pmid:16866917
Crisby M The role of pleiotropic effects of statins in dementia. 2006 Acta Neurol. Scand., Suppl.c pmid:16866920
Chana RS and Brunskill NJ Thiazolidinediones inhibit albumin uptake by proximal tubular cells through a mechanism independent of peroxisome proliferator activated receptor gamma. 2006 Am. J. Nephrol. pmid:16508249
Macreadie IG et al. Growth inhibition of Candida species and Aspergillus fumigatus by statins. 2006 FEMS Microbiol. Lett. pmid:16907733
Kosztáczky B et al. Neuropeptides induced a pronounced and statin-sensitive dysregulation of mevalonate cycle in human monocytes of patients with hypercholesterolemia. 2006 Neuropeptides pmid:17049599
Ridsdale A et al. Cholesterol is required for efficient endoplasmic reticulum-to-Golgi transport of secretory membrane proteins. 2006 Mol. Biol. Cell pmid:16452637
Gómez-Hernández A et al. Atorvastatin reduces the expression of prostaglandin E2 receptors in human carotid atherosclerotic plaques and monocytic cells: potential implications for plaque stabilization. 2006 J. Cardiovasc. Pharmacol. pmid:16424787
Kinderlerer AR et al. Statin-induced expression of CD59 on vascular endothelium in hypoxia: a potential mechanism for the anti-inflammatory actions of statins in rheumatoid arthritis. 2006 Arthritis Res. Ther. pmid:16859540
Kotti TJ et al. Brain cholesterol turnover required for geranylgeraniol production and learning in mice. 2006 Proc. Natl. Acad. Sci. U.S.A. pmid:16505352
Sato M et al. Effects of exogenous mevalonic acid on sterol lipid classes in Larix kaempferi callus. 2006 J Oleo Sci pmid:17693695
Kuzina V et al. Relationships among the biosyntheses of ubiquinone, carotene, sterols, and triacylglycerols in Zygomycetes. 2006 Arch. Microbiol. pmid:17009023
Li JQ et al. Atorvastatin reduces plasminogen activator inhibitor-1 expression in adipose tissue of atherosclerotic rabbits. 2006 Clin. Chim. Acta pmid:16507303
Parsons RB et al. Statins inhibit the dimerization of beta-secretase via both isoprenoid- and cholesterol-mediated mechanisms. 2006 Biochem. J. pmid:16803455
Brinkkoetter PT et al. Atorvastatin interferes with activation of human CD4(+) T cells via inhibition of small guanosine triphosphatase (GTPase) activity and caspase-independent apoptosis. 2006 Clin. Exp. Immunol. pmid:17100774
Mandey SH et al. A role for geranylgeranylation in interleukin-1beta secretion. 2006 Arthritis Rheum. pmid:17075828
Ural AU et al. In vitro synergistic cytoreductive effects of zoledronic acid and radiation on breast cancer cells. 2006 Breast Cancer Res. pmid:16925824
van Hellemond JJ and Tielens AG Adaptations in the lipid metabolism of the protozoan parasite Trypanosoma brucei. 2006 FEBS Lett. pmid:16920110
Saini GS et al. Validation of the LC-MS/MS method for the quantification of mevalonic acid in human plasma and determination of the matrix effect. 2006 J. Lipid Res. pmid:16861623
Yi P et al. The mevalonate pathway controls heart formation in Drosophila by isoprenylation of Ggamma1. 2006 Science pmid:16857902
Dimitroulakos J et al. Strategies to enhance epidermal growth factor inhibition: targeting the mevalonate pathway. 2006 Clin. Cancer Res. pmid:16857822
Xu H et al. HMG-CoA reductase inhibitor simvastatin mitigates VEGF-induced "inside-out" signaling to extracellular matrix by preventing RhoA activation. 2006 Am. J. Physiol. Renal Physiol. pmid:16774905
Kawasaki T et al. Biosynthesis of a natural polyketide-isoprenoid hybrid compound, furaquinocin A: identification and heterologous expression of the gene cluster. 2006 J. Bacteriol. pmid:16452404
Haas D and Hoffmann GF Mevalonate kinase deficiencies: from mevalonic aciduria to hyperimmunoglobulinemia D syndrome. 2006 Orphanet J Rare Dis pmid:16722536
Solito E et al. Post-translational modification plays an essential role in the translocation of annexin A1 from the cytoplasm to the cell surface. 2006 FASEB J. pmid:16720734
Chemler JA et al. Biosynthesis of isoprenoids, polyunsaturated fatty acids and flavonoids in Saccharomyces cerevisiae. 2006 Microb. Cell Fact. pmid:16719921
Silvander M et al. A new water-based topical carrier with polar skin-lipids. 2006 Lipids Health Dis pmid:16672068
Coward WR et al. Statin-induced proinflammatory response in mitogen-activated peripheral blood mononuclear cells through the activation of caspase-1 and IL-18 secretion in monocytes. 2006 J. Immunol. pmid:16621994
Neville-Webbe HL et al. Mechanisms of the synergistic interaction between the bisphosphonate zoledronic acid and the chemotherapy agent paclitaxel in breast cancer cells in vitro. 2006 Tumour Biol. pmid:16582586
Rattan R et al. Rho/ROCK pathway as a target of tumor therapy. 2006 J. Neurosci. Res. pmid:16385577
Wang J et al. Anti-inflammatory effect of pitavastatin on NF-kappaB activated by TNF-alpha in hepatocellular carcinoma cells. 2006 Biol. Pharm. Bull. pmid:16595893
Benetka W et al. Farnesylation or geranylgeranylation? Efficient assays for testing protein prenylation in vitro and in vivo. 2006 BMC Biochem. pmid:16507103
Xu L et al. [Effects of simvastatin on DNA synthesis in rat cardiac fibroblasts]. 2006 Nan Fang Yi Ke Da Xue Xue Bao pmid:16503530
Riganti C et al. Statins revert doxorubicin resistance via nitric oxide in malignant mesothelioma. 2006 Int. J. Cancer pmid:16450390
Ramasubbu K and Mann DL The emerging role of statins in the treatment of heart failure. 2006 J. Am. Coll. Cardiol. pmid:16412858
Christensen M et al. Simvastatin protection against acute immune-mediated glomerulonephritis in mice. 2006 Kidney Int. pmid:16407885
González-Fernández L et al. Cleavage of focal adhesion proteins and PKCdelta during lovastatin-induced apoptosis in spontaneously immortalized rat brain neuroblasts. 2006 FEBS J. pmid:16367743
Zahiri HS et al. Coenzyme Q10 production in recombinant Escherichia coli strains engineered with a heterologous decaprenyl diphosphate synthase gene and foreign mevalonate pathway. 2006 Metab. Eng. pmid:16815062
Pappu AS et al. Increased nonsterol isoprenoids, dolichol and ubiquinone, in the Smith-Lemli-Opitz syndrome: effects of dietary cholesterol. 2006 J. Lipid Res. pmid:16983147
Yoon SH et al. Enhanced lycopene production in Escherichia coli engineered to synthesize isopentenyl diphosphate and dimethylallyl diphosphate from mevalonate. 2006 Biotechnol. Bioeng. pmid:16547999
Nagashima T et al. Apoptosis of rheumatoid synovial cells by statins through the blocking of protein geranylgeranylation: a potential therapeutic approach to rheumatoid arthritis. 2006 Arthritis Rheum. pmid:16447234
Yokota K et al. Simvastatin inhibits production of interleukin 6 (IL-6) and IL-8 and cell proliferation induced by tumor necrosis factor-alpha in fibroblast-like synoviocytes from patients with rheumatoid arthritis. 2006 J. Rheumatol. pmid:16511915
Grochowski LL et al. Methanocaldococcus jannaschii uses a modified mevalonate pathway for biosynthesis of isopentenyl diphosphate. 2006 J. Bacteriol. pmid:16621811
Alegret M and Silvestre JS Pleiotropic effects of statins and related pharmacological experimental approaches. 2006 Methods Find Exp Clin Pharmacol pmid:17200729
Muñoz-García B et al. Fn14 is upregulated in cytokine-stimulated vascular smooth muscle cells and is expressed in human carotid atherosclerotic plaques: modulation by atorvastatin. 2006 Stroke pmid:16809572
Shang F et al. Simvastatin inhibits lipopolysaccharide-induced tumor necrosis factor-alpha expression in neonatal rat cardiomyocytes: The role of reactive oxygen species. 2006 Biochem. Biophys. Res. Commun. pmid:17094942
Issat T et al. Berberine, a natural cholesterol reducing product, exerts antitumor cytostatic/cytotoxic effects independently from the mevalonate pathway. 2006 Oncol. Rep. pmid:17089049
Kuwana M Potential benefit of statins for vascular disease in systemic sclerosis. 2006 Curr Opin Rheumatol pmid:17053504
Thompson K et al. Alkylamines cause Vgamma9Vdelta2 T-cell activation and proliferation by inhibiting the mevalonate pathway. 2006 Blood pmid:16179378
van Beek E et al. Independent pathways in the modulation of osteoclastic resorption by intermediates of the mevalonate biosynthetic pathway: the role of the retinoic acid receptor. 2006 Bone pmid:16165408
Hamadmad SN et al. Erythropoietin receptor signal transduction requires protein geranylgeranylation. 2006 J. Pharmacol. Exp. Ther. pmid:16203826
Qiu Y and Li D Bifunctional inhibitors of mevalonate kinase and mevalonate 5-diphosphate decarboxylase. 2006 Org. Lett. pmid:16524256
Qiu Y and Li D Inhibition of mevalonate 5-diphosphate decarboxylase by fluorinated substrate analogs. 2006 Biochim. Biophys. Acta pmid:16626865
Beckman JA and Creager MA The nonlipid effects of statins on endothelial function. 2006 Trends Cardiovasc. Med. pmid:16781949
Caruso MG and Notarnicola M Biochemical changes of mevalonate pathway in human colorectal cancer. 2005 Sep-Oct Anticancer Res. pmid:16101154
Nawarskas JJ HMG-CoA reductase inhibitors and coenzyme Q10. 2005 Mar-Apr Cardiol Rev pmid:15705257
Akiyama K et al. Antitumor effect of geranylamine derivatives on human hepatoma. 2005 Jan-Feb In Vivo pmid:15796170
Baker SK and Tarnopolsky MA Statin-associated neuromyotoxicity. 2005 Drugs Today pmid:16034491
Seker T et al. Analysis of acyl CoA ester intermediates of the mevalonate pathway in Saccharomyces cerevisiae. 2005 Appl. Microbiol. Biotechnol. pmid:15448940
Donovan JM et al. Effects of colesevelam HC1 on sterol and bile acid excretion in patients with type IIa hypercholesterolemia. 2005 Dig. Dis. Sci. pmid:16047465
Hargreaves IP et al. The effect of HMG-CoA reductase inhibitors on coenzyme Q10: possible biochemical/clinical implications. 2005 Drug Saf pmid:16048353
Madonna R et al. Simvastatin attenuates expression of cytokine-inducible nitric-oxide synthase in embryonic cardiac myoblasts. 2005 J. Biol. Chem. pmid:15705589
Pedrini S et al. Modulation of statin-activated shedding of Alzheimer APP ectodomain by ROCK. 2005 PLoS Med. pmid:15647781
Cordle A and Landreth G 3-Hydroxy-3-methylglutaryl-coenzyme A reductase inhibitors attenuate beta-amyloid-induced microglial inflammatory responses. 2005 J. Neurosci. pmid:15647473
Hewitt RE et al. The bisphosphonate acute phase response: rapid and copious production of proinflammatory cytokines by peripheral blood gd T cells in response to aminobisphosphonates is inhibited by statins. 2005 Clin. Exp. Immunol. pmid:15606619
Wu B et al. Paradoxical effects of statins on aortic valve myofibroblasts and osteoblasts: implications for end-stage valvular heart disease. 2005 Arterioscler. Thromb. Vasc. Biol. pmid:15618546